Canada Markets close in 2 hrs 53 mins

Aptose Biosciences Inc. (APS.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.8100+0.0300 (+3.85%)
As of 11:45AM EDT. Market open.
Currency in CAD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.42
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 33.5300
52 Week Low 30.7500
50-Day Moving Average 30.9714
200-Day Moving Average 31.3245

Share Statistics

Avg Vol (3 month) 312.13k
Avg Vol (10 day) 37.87k
Shares Outstanding 588.95M
Implied Shares Outstanding 6N/A
Float 879.96M
% Held by Insiders 15.36%
% Held by Institutions 129.61%
Shares Short (Jul 14, 2022) 4789.41k
Short Ratio (Jul 14, 2022) 463.11
Short % of Float (Jul 14, 2022) 40.87%
Short % of Shares Outstanding (Jul 14, 2022) 40.86%
Shares Short (prior month Jun 14, 2022) 4814.91k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:12
Last Split Date 3Oct 05, 2014

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-40.40%
Return on Equity (ttm)-69.39%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -60.55M
Net Income Avi to Common (ttm)-60.61M
Diluted EPS (ttm)-0.8290
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)69.51M
Total Cash Per Share (mrq)0.75
Total Debt (mrq)529k
Total Debt/Equity (mrq)0.81
Current Ratio (mrq)9.83
Book Value Per Share (mrq)1.34

Cash Flow Statement

Operating Cash Flow (ttm)-42.57M
Levered Free Cash Flow (ttm)-27.04M